Welcome!
DBS Group Research
Broker's Calls
ThaiBev shares see high trading volumes after results; analysts keep ‘buy’ calls and TPs
Thai Beverage (ThaiBev) was the most heavily traded counter on Nov 22 with some 31.36 million shares changed hands as at 11.31am.
6 days ago
Broker's Calls
DBS picks four ETFs to benefit from AI and cloud computing boom
First Trust Cloud Computing; Global X Cloud Computing ETF; iShares Cybersecurity and Tech ETF and Global X Cybersecurity ETF are DBS’s top picks.
6 days ago
Broker's Calls
Brokers’ Digest: AEM, Prime US REIT, Hyphens Pharma, Seatrium, Valuetronics, DFI Retail Group, CDG, Centurion, Sembcorp
Here's what the analysts have to say this week.
6 days ago
Broker's Calls
DBS sees potential IPO of ThaiBev's ‘F&B Co’ after series of corporate actions
Analysts Chee Zheng Feng and Andy Sim have kept their "buy" call with a higher target price of 77 cents.
11 days ago
Broker's Calls
Analysts mixed on AEM; UOBKH keeps ‘sell’, DBS keeps ‘buy’
AEM has raised its 2HFY2024 revenue guidance to $190 million to $210 million, up from $160 million to $180 million, due to its key customer bringing forward systems’ order from FY2025 into 4QFY2024.
13 days ago
Broker's Calls
Analysts raise TPs on Sea after another ‘blowout’ quarter
The analysts see an improved outlook for Shopee amid stabilisation of the Asean e-commerce competitive landscape.
13 days ago
Broker's Calls
DBS lowers TP for Acrophyte Hospitality Trust formerly known as ARA US Hospitality Trust to 25 US cents
The analysts keep their “buy” call, but revise down their near-term recovery outlook for the REIT.
15 days ago
Broker's Calls
‘Buy’ Grab as 3QFY2024 earnings hitting all the right notes, analysts say
The Maybank, DBS and CGSI analysts have all raised their target prices to US$5.40, US$5.16 and US$4.90 respectively.
15 days ago
Broker's Calls
Analysts upgrade calls and TPs on UOB as they look forward to the bank’s capital management plans
The analysts' target prices now range from $37 to $41.
16 days ago
Broker's Calls
DBS downgrades SIAEC to ‘hold’ amid ‘lacklustre’ earnings prospects
Analyst Jason Sum has also lowered his target price to $2.50 from $2.80 previously.
16 days ago